FDA Grants BD 510(k) Clearance for New Immunological Dx System

Jul 19, 2017

|

The story has been updated to correct the spelling of John Ledek's name. We regret the error.

NEW YORK (360Dx) – Becton Dickinson announced today that it has received 510(k) clearance from the US Food and Drug Administration for its BD FACSLyric flow cytometer system.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

FDA Grants BD 510(k) Clearance for New Immunological Dx System

To read the full story....

Breaking News

DiaSorin Molecular Gets CE Mark for Flu, RSV Assay

Quidel Preliminary Q2 Revenues Jump More Than 86 Percent

FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test

Chembio Diagnostics Trims Q2 Revenue Outlook, Plans New EUA for Serology Test

Asuragen Receives CE Mark for Spinal Muscular Atrophy Assay

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

What's Popular?

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

NanoDiagnostics Closes $18M Series C Round

InBios International Gets Emergency Use Authorization for Second Coronavirus Antibody Test

Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test

Centogene Gets Emergency Use Authorization for PCR-Based Coronavirus Test

Sponsorships